Nanoparticle-Based gene therapy strategies in retinal delivery

Area of Science:

• Ophthalmology
• Nanotechnology
• Gene Therapy

Background:

• Vision loss and blindness are major global health concerns with diverse causes.
• Many cases of vision impairment remain untreated despite medical advancements.
• Gene delivery presents a promising avenue for managing challenging vision loss conditions.

Purpose of the Study:

• To review the application of nanotechnology-based gene delivery systems for vision impairment.
• To focus on lipid and polymer nanoparticles, and quantum dots as ocular gene delivery vectors.
• To highlight emerging technologies in the field of vision restoration.

Main Methods:

• Review of current literature on nanotechnology applications in ophthalmology.
• Focus on non-viral gene delivery systems, specifically nanoparticles and quantum dots.
• Analysis of gene delivery vectors targeting ocular tissues.

Main Results:

• Nanoparticle-based gene delivery systems show potential for treating vision impairment.
• Lipid nanoparticles, polymer nanoparticles, and quantum dots are effective vectors for ocular gene delivery.
• Emerging technologies are being developed to further advance vision restoration.

Conclusions:

• Nanotechnology, particularly non-viral gene delivery using nanoparticles, offers a promising strategy for addressing vision loss.
• Further research and development in this area could lead to new treatments for previously untreatable blinding conditions.
• The use of lipid and polymer nanoparticles, and quantum dots represents a significant advancement in ocular gene therapy.